RESEARCH-USE BIOSIMILAR ANTIBODY
Palivizumab
Monoclonal antibody · IgG1 kappa
Palivizumab is a humanised biosimilar reference antibody directed against Respiratory Syncytial Virus Glycoprotein F.
TARGETRSV gpF
YMonoclonal antibody
CATALOGSC-BS-291
CATALOG NUMBERSC-BS-291
MOLECULAR WEIGHTApprox. 147.7 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Palivizumab is a humanised biosimilar reference antibody directed against Respiratory Syncytial Virus Glycoprotein F.
Palivizumab is a recombinant research-use antibody directed against RSV gpF.